title: Authors' Reply to Lambarth: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review".
authors.affiliation: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden.|Department of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden.
authors.forename: Karin
authors.initials: K
authors.lastname: Wirdefeldt
authors.affiliation: Department of Neurology, Skåne University Hospital, Lund, Sweden.|Klinikum-Bremerhaven, Bremerhaven, Germany.
authors.forename: Per
authors.initials: P
authors.lastname: Odin
authors.affiliation: Department of Neuroscience, Neurology, Uppsala University, Akademiska sjukhuset, 75185, Uppsala, Sweden. dag.nyholm@neuro.uu.se.
authors.forename: Dag
authors.identifier: 0000-0001-9776-7715
authors.initials: D
authors.lastname: Nyholm
mesh_terms: D000978:Antiparkinson Agents / Q000008:administration & dosage*; D002230:Carbidopa / Q000008:administration & dosage*; D004338:Drug Combinations; D005782:Gels / Q000627:therapeutic use; D006801:Humans; D007422:Intestines / Q000187:drug effects / Q000502:physiology*; D007980:Levodopa / Q000008:administration & dosage*; D010300:Parkinson Disease / Q000188:drug therapy*; D012196:Review Literature as Topic
chemical_list: D000978:Antiparkinson Agents; D004338:Drug Combinations; D005782:Gels; C009265:carbidopa, levodopa drug combination; D007980:Levodopa; D002230:Carbidopa